±ÙÀ§°æ°ñÀý°ñ¼ú Ç÷¹ÀÌÆ®(High Tibial Osteotomy Plates) ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È CAGR 6%·Î ÃßÀÌÇÏ¸ç ¼ºÀå ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
COVID-19 ÆÒµ¥¹ÍÀº ±ÙÀ§°æ°ñÀý°ñ¼ú Ç÷¹ÀÌÆ® ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÆÒµ¥¹ÍÀÇ Ãʱ⿡´Â Á¤Çü¿Ü°ú ¼ö¼úÀÌ ¿¬±âµÇ¾ú°í º´¿ø°ú ¿Ü°úÀÇ»ç´Â °ñÀý ¼ö¼úÀ» Æ÷ÇÔÇÑ ¼±ÅÃÀû ¼ö¼úÀÇ ¿¬±â ¹× Áß´ÜÀ» ±Ç°íÇß½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 1¿ù, ¸ÞµðÄÉ¾î ¸ÞµðÄÉÀÌµå ¼ºñ½º ¼¾ÅÍ(CMS), ¹Ì±¹ ¿Ü°úÇÐȸ(ACS) ¹× ¹Ì±¹ ¸¶Ãë °úÇÐȸ(ASA)¿Í °°Àº ¿©·¯ ´Üü´Â COVID-19 ÆÒµ¥¹Í¿¡ ´ëÀÀÇÏ¿© ¼±ÅÃÀû ¼ö¼ú ¼ö¼úÀÇ ÀáÁ¤ÀûÀÎ Áß´ÜÀ» ±Ç°íÇß½À´Ï´Ù. Á¤Çü¿Ü°ú ½Ã¼³ÀÇ ´ëºÎºÐÀº COVID-19 º´¿ø ¹× Ŭ¸®´ÐÀ¸·Î ÀüȯµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº ¼¼°è¿¡¼ °ñÀý ¼ö¼úÀÇ ¼ö¸¦ °¨¼Ò½ÃŰ°í ±ÙÀ§°æ°ñÀý°ñ¼ú Ç÷¹ÀÌÆ® ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ±×·¯³ª ¼¼°è ±ÔÁ¦°¡ ¿Ïȵǰí Áúº´ °ËÁø ¼ºñ½º°¡ Àç°³µÊ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀº ÆÒµ¥¹Í ÀÌÈÄ ¾ÈÁ¤µÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀåÀº ±Ù°ñ°Ý°è ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ½ºÆ÷Ã÷ °ü·Ã Ȱµ¿ ¹× ±³Åë»ç°í Áõ°¡, °ñÀý Ç÷¹ÀÌÆ®ÀÇ ÃÖ±Ù Áøº¸¿¡ Å©°Ô ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î WHOÀÇ 2021³â Åë°è¿¡ µû¸£¸é ¼¼°è 17¾ï 1,000¸¸ ¸íÀÌ ±Ù°ñ°Ý°è Àå¾Ö·Î °íÅë¹Þ°í ÀÖ´Ù°í ÇÕ´Ï´Ù. µû¶ó¼, ±Ù°ñ°Ý°è Àå¾Ö Áõ°¡´Â ±ÙÀ§°æ°ñÀý°ñ¼ú µµÀÔ È®´ë¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ±ÙÀ§°æ°ñÀý°ñ¼ú Ç÷¹ÀÌÆ® ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, °ñÀý Ç÷¹ÀÌÆ® ÃÖ±Ù Áøº¸´Â ±ÙÀ§°æ°ñÀý°ñ¼ú Ç÷¹ÀÌÆ® ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 7¿ù ¿µ±¹ ¹ö½º ´ëÇÐÀÇ Centre for Therapeutic Innovation(CTI)Àº ¼¼°è ÃÖÃÊÀÇ 3D ÇÁ¸°ÅÍ·Î ±ÙÀ§°æ°ñÀý°ñ¼ú ÀåÄ¡¸¦ µµÀÔÇÏ¿© ¿µ±¹¿¡¼ ÀÓ»ó ½ÃÇè ½ÂÀÎÀ» ¾ò¾ú½À´Ï´Ù. À̰ÍÀº Bath University Ä¡·á Çõ½Å ¼¾ÅÍ(CTI)ÀÇ ¿£Áö´Ï¾î°¡ °³¹ß ÇÑ °³Àο¡ ¸Â´Â Ãʱ⠺¯Çü¼º ¹«¸ °üÀýÁõ Ä¡·á¹ýÀÔ´Ï´Ù. ÃÖ÷´Ü 3D ±Ý¼Ó Àμ⠱â¼úÀ» »ç¿ëÇÏ¿© ÀÇ·á µî±Þ ƼŸ´½ ÇÕ±Ý Ç÷¹ÀÌÆ®¸¦ ¸¸µì´Ï´Ù. Tailored Osteotomy for Knee Alignment(TOKA) Ä¡·á´Â ȯÀÚÀÇ ¹«¸À» Á¤º¹ÇÏ´Â ¼ö¼ú ÀýÂ÷¸¦ °³¼±ÇÏ¿© ±âÁ¸ÀÇ ÀϹÝÀûÀÎ Ç÷¹ÀÌÆ®º¸´Ù Æí¾ÈÇÏ°í ¾ÈÁ¤ÀûÀ̸ç üÁßÀ» °ßµô ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸°¡ ±ÙÀ§°æ°ñÀý°ñ¼ú Ç÷¹ÀÌÆ® ¼ö¿ä¸¦ ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
µû¶ó¼ ÀÌ ½ÃÀåÀº ¾Õ¼ ¾ð±ÞÇÑ ¿äÀεé·ÎºÎÅÍ ¿¹Ãø ±â°£ µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±×·¯³ª Ç÷Àü, °¨¿°, °¡µ¿¿ª(ROM) ºÎÁ·, °ñÀý ¼ö¼úÀÇ °í¾× ºñ¿ë µî ¼ö¼ú¿¡ µû¸¥ ÇÕº´ÁõÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.
¿ÀÇÁ´× ¿þÁö °ñÀý¼úÀº Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ ±â¼úÀº ¹«¸ ³»ºÎ¸¦ Àý°³ÇÏ°í °æ°ñ¿¡ »À À̽ÄÀ» ¼öÇàÇÕ´Ï´Ù. ÀÌ ÀÌ½ÄÆíÀº ±Ý¼Ó Ç÷¹ÀÌÆ®¿Í ³ª»ç·Î °íÁ¤µË´Ï´Ù. ¹«¸ ¾ÈÂÊÀ» Àý°³ÇÏ°í °æ°ñ¿¡ »À À̽ÄÀ»ÇÕ´Ï´Ù. º¯Çü¼º ¹«¸ °üÀýÁõ°ú ´Ù¾çÇÑ º¯ÇüÀ¸·Î °í¹ÎÇϴ ȯÀÚÀÇ Ä¡·á¹ýÀ¸·Î È®¸³µÇ¾î ÀÖ½À´Ï´Ù. ¿ÀÇÁ´× ¿þÁö °ñÀý¼úÀº À߸øµÈ Á¤·Ä ÁõÈıºÀÇ Ä¡·á¿¡ ÀûÇÕÇÕ´Ï´Ù. °üÀý¿°À» ¾Î°í Àִ ȯÀÚÀÇ °æ¿ì, ¼ö¼úÀº ÅðÇà °úÁ¤À» ´ÊÃß°í ÅëÁõÀ» ¿ÏȽÃ۰í À¯È¿ ÇÏÁßÀ» ÁÙÀÓÀ¸·Î½á ´Ù¸®ÀÇ Á¤·ÄÀ» ±³Á¤ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. CDC¿¡ µû¸£¸é 2021³â 10¿ù ¹Ì±¹ ¼ºÀÎÀÇ ¾à 4¸í Áß 1¸í(23.7%), ¾à 5,850¸¸ ¸íÀÌ ÀÇ»ç·ÎºÎÅÍ °üÀý¿°À¸·Î Áø´ÜµÇ¾ú½À´Ï´Ù. ij³ª´Ù Á¤ºÎ¿¡ µû¸£¸é 2021³â 9¿ù¿¡´Â 16¼¼ ÀÌ»óÀÇ Ä³³ª´ÙÀÎ Áß 374,000¸í(1.2%)ÀÌ ·ù¸¶Æ¼½º °üÀý¿°À¸·Î Áø´Ü¹Þ°í »ì°í ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ °üÀý¿°ÀÇ ÃßÁ¤ ÀÌȯÀ²ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °ñ°üÀý¿°À¸·Î °íÅë¹Þ´Â »ç¶÷ÀÇ ¼öµµ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¾î ¿ÀÇÁ´× ¿þÁö °ñÀý¼ú ¼ö¿ä¸¦ Áõ°¡½Ãŵ´Ï´Ù.
³ëÀÎÀº »À °ü·Ã º¯Çü¿¡ ½Ã´Þ¸®±â ½±½À´Ï´Ù. World Population Prospects 2022¿¡ µû¸£¸é ¼¼°è Àα¸¿¡¼ Â÷ÁöÇÏ´Â 65¼¼ ÀÌ»óÀÇ ³ëÀÎ ºñÀ²Àº ÇöÀç 10%¿¡¼ 27³â¿¡´Â 16%·Î »ó½ÂÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼¼°èÀÇ 65¼¼ ÀÌ»óÀÇ Àα¸´Â 27³â¿¡´Â 5¼¼ ¹Ì¸¸ÀÇ ¾î¸°ÀÌÀÇ 2¹è ÀÌ»ó, 12¼¼ ¹Ì¸¸ÀÇ ¾î¸°ÀÌ¿Í °ÅÀÇ °°Àº ¼ö°¡ µÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. µû¶ó¼, Àα¸ Áõ°¡°¡ ¿¹»óµÊ¿¡ µû¶ó ¿ÀÇÁ´× ¿þÁö °ñÀý¼ú µµÀÔÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ¿Í °°ÀÌ ¾Õ¼ ¾ð±ÞÇÑ ¿äÀο¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È Á¶»çµÈ ½ÃÀåÀº Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ±ÙÀ§°æ°ñÀý°ñ¼ú Ç÷¹ÀÌÆ® ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÏ¹Ì ºÎ¹®ÀÇ ±â¿©´Â Å« °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ª ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀº »À °ü·Ã Áúº´ Áõ°¡¿Í °Ç° °ü¸® ÀÎÇÁ¶óÀÇ Á¤ºñÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 7¿ù¿¡ Frontiers in Physiology°¡ ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é, ±Ù°ñ°Ý°è Àå¾Ö´Â °¡Àå ÀϹÝÀûÀ¸·Î º¸°íµÈ º´¸®ÇÐ Áß ÇϳªÀÔ´Ï´Ù. ¹Ì±¹¿¡¼´Â Àå¾ÖÀÇ ÁÖµÈ ¿øÀÎÀÌ µÇ¾î 50¼¼ ÀÌ»óÀÇ ¸¸¼º ÁúȯÀÇ Àý¹Ý ÀÌ»óÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼ »À °ü·Ã Áúȯ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àý´ÜÀ¸·Î À̾îÁö´Â ±³Åë»ç°í ¹ß»ý·ü Áõ°¡µµ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ µµ·Î±³Åë¾ÈÀü±¹ÀÌ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2022³â 5¿ù ±³Åë»ç°í»çÀÚ¼ö´Â Àü³â´ëºñ 10.5% Áõ°¡Çß½À´Ï´Ù. ¶Ç, µµ½ÃÀÇ µµ·Î¿¡¼ »ç¸Á »ç°í´Â Àü³âÀÇ 57.0%·ÎºÎÅÍ 2021³â 3¿ù¿¡´Â 62.0%¿Í 5.0% Áõ°¡Çß´Ù°í º¸°íµÇ°í ÀÖ½À´Ï´Ù. µû¶ó¼ ÀÌ·¯ÇÑ ¿äÀÎÀº ±ÙÀ§°æ°ñÀý°ñ¼ú ¼ö¿ä¸¦ Áõ°¡½ÃŰ°í ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» À̲ø °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ 2021³â 8¿ù, Zimmer Biomet Holdings, Inc.¿Í Canary MedicalÀº ¹Ì±¹ FDAÀÇ De Novo ºÐ·ùÀÇ ºÎ¿©¿Í Àΰø ½½°üÀý Àüġȯ¼ú¿ëÀ¸·Î FDA¿¡ Çã°¡µÈ ¼¼°è ÃÖÃÊÀÇ À¯ÀÏÇÑ ½º¸¶Æ® ¹«¸ÀÎ Persona IQÀÇ °æ°ñ ¿¬ÀåºÎÀÇ ÆÇ¸Å Çã°¡¸¦ ÃëµæÇß½À´Ï´Ù.
µû¶ó¼, ºÏ¹Ì¿¡¼ Á¶»çµÈ ½ÃÀåÀº À§ÀÇ ¿äÀε鿡 ÀÇÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
±ÙÀ§°æ°ñÀý°ñ¼ú Ç÷¹ÀÌÆ® ½ÃÀåÀº ¼¼°è ¹× Áö¿ªÀûÀ¸·Î »ç¾÷À» Àü°³ÇÏ´Â ¼Ò¼öÀÇ ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇØ º»ÁúÀûÀ¸·Î ÅëÇյ˴ϴÙ. °æÀï ±¸µµ¿¡´Â Johnson & Johnson, Arthrex Inc., Smith & Nephew, B. Braun SE, Stryker Corporation µî ½ÃÀå Á¡À¯À²ÀÌ ¶Ù¾î³ª°í À¯¸íÇÑ ±¹Á¦ ¹× Áö¿ª ±â¾÷ÀÇ ºÐ¼®ÀÌ Æ÷ÇԵ˴ϴÙ.
The high tibial osteotomy plates market is expected to register a CAGR of 6% during the forecast period.
The COVID-19 pandemic had a major impact on the high tibial osteotomy plates market. Orthopedic procedures were postponed at the beginning of the pandemic as the hospitals and surgeons were advised to postpone or cancel elective procedures, including osteotomy surgeries. For instance, in January 2021, the Centers for Medicare and Medicaid Services (CMS) and several organizations, such as the American College of Surgeons (ACS) and the American Society of Anesthesiologists (ASA), recommended the interim cancelation of elective surgical procedures in response to the COVID-19 pandemic. Most of the orthopaedic facilities were converted to COVID-19 hospitals and clinics. These factors resulted in a decrease in the number of osteotomy surgeries performed worldwide, thereby affecting the demand for high tibial osteotomy plates. However, the market's growth is stabilizing post-pandemic as the worldwide restrictions have eased down and disease screening services have been resumed.
The market's growth can be largely attributed to the increasing incidence rate of musculoskeletal conditions, rising sports-related activities and road injuries, and recent advances in osteotomy plates. For instance, according to the WHO 2021 statistics, an estimated 1.71 billion people suffer from musculoskeletal disorders worldwide. Thus, the increasing musculoskeletal disorders are contributing to the growing adoption of high-tibial osteotomy procedures, driving the demand for high-tibial osteotomy plates.
Moreover, recent advances in osteotomy plates are anticipated to fuel the demand for high-tibial osteotomy plates. For instance, in July 2021, the University of Bath's Centre for Therapeutic Innovation (CTI), United Kingdom, introduced the world's first 3D printed high tibial osteotomy device and procedure given for approval for trials in the United Kingdom. It is a personalized early knee osteoarthritis treatment developed by engineers at the University of Bath's Centre for Therapeutic Innovation (CTI). It uses state-of-the-art 3D metal printing technology to make personalized medical-grade titanium alloy plates. The Tailored Osteotomy for Knee Alignment (TOKA) treatment improves the operative procedure to realign a patient's knee, making them comfortable, stable, and better able to bear weight than existing generic plates. Such advances are anticipated to boost the demand for high tibial osteotomy plates.
Thus, the market studied is anticipated to witness significant growth over the forecast period due to the aforementioned factors. However, complications associated with the procedure, such as blood clots, infection, lack of range of motion (ROM), and the high cost of osteotomy surgery, are some factors impeding the market's growth.
The opening wedge osteotomy segment is anticipated to register significant growth. The technique involves an incision on the knee's inside to replace a bone graft into the tibia bone. This graft is made to hold in place with metal plates and screws. It involves an incision inside the knee to place a bone graft into the tibia. It is an established procedure to treat patients suffering from knee osteoarthritis and various deformities. Opening wedge osteotomy is preferred for the treatment of miserable misalignment syndrome. For patients who have arthritis, the procedure aims to slow the degeneration process to relieve pain and correct the lower extremity alignment by reducing the effective load. According to the CDC, in October 2021, about 1 in 4 United States adults (23.7%), or about 58.5 million people, have doctor-diagnosed arthritis. According to the Government of Canada, in September 2021, 374,000 (1.2%) Canadians aged 16 years and older live with diagnosed rheumatoid arthritis. Thus, with the estimated increase in arthritis incidence, the number of people suffering from osteoarthritis is also anticipated to increase, augmenting the demand for opening wedge osteotomy.
Older people are prone to suffer from bone-related deformities. According to the World Population Prospects 2022, the share of the global population aged 65 years or above is projected to rise from 10% in the current year to 16% in 27 years. The number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age five and about the same as that of children under age 12, in 27 years. Therefore, with the anticipated increase in the population, the adoption of the opening wedge osteotomy technique is anticipated to increase. Thus, the market studied is expected to grow significantly over the forecast period due to the aforementioned factors.
The contribution of the North American segment to the high tibial osteotomy plate market's growth is expected to be significant during the forecast period. The major factors contributing to the growth of the market in the region are increasing incidences of bone-related disorders and developed healthcare infrastructure. For instance, according to the article published by the Frontiers in Physiology in July 2022, musculoskeletal disorders are one of the most commonly reported medical conditions. They are the leading cause of disability in the United States, accounting for more than half of chronic conditions in people over 50. Thus, an increase in bone-related disorders is expected to drive the growth of the market.
The increasing incidence of road accidents leading to amputations is also anticipated to propel the market's growth over the forecast period. For instance, according to the data published by the National Highway Traffic Safety Administration in the United States, in May 2022, traffic fatalities increased 10.5% from the previous year. It also reported that fatalities on urban roads rose from 57.0% in the previous year to 62.0% in March 2021, a 5.0% increase. Hence, such factors are expected to increase the demand for high tibial osteotomy, driving the market's growth over the forecast period.
Moreover, in August 2021, Zimmer Biomet Holdings, Inc. and Canary Medical received a U.S. FDA De Novo classification grant and authorization to market the tibial extension for Persona IQ, the world's first and only smart knee cleared by the FDA for total knee replacement surgery.
Hence, the market studied in North America is expected to witness significant growth over the forecast period due to the above-mentioned factors.
The high tibial osteotomy plates market is consolidated in nature due to the presence of a few companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well-known, including Johnson & Johnson, Arthrex Inc., Smith & Nephew, B. Braun SE, and Stryker Corporation, among others.